About Cellply
Cellply is a company based in Bologna (Italy) founded in 2013 by Roberto Guerrieri and Massimo Bocchi. Cellply has raised $8.05 million across 10 funding rounds from investors including European Commission, European Union and Liftt. Cellply offers products and services including VivaCyte platform. Cellply operates in a competitive market with competitors including Kiyatec, Lucid Scientific, DiscoverX, CytoTronics and Saguaro, among others.
- Headquarter Bologna, Italy
- Founders Roberto Guerrieri, Massimo Bocchi
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cellply S.R.L.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$8.05 M (USD)
in 10 rounds
-
Latest Funding Round
Not available
-
Investors
European Commission
& 11 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cellply
Cellply offers a comprehensive portfolio of products and services, including VivaCyte platform.
Enables automated characterization of immune cells for cell therapy research
People of Cellply
Unlock access to complete
Funding Insights of Cellply
Cellply has successfully raised a total of $8.05M across 10 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Cellply
Cellply has secured backing from 12 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include European Commission, European Union and Liftt.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on multiple sectors
|
Locked | Locked | Locked | |
|
Potato farming, grain marketing, and equipment services associated with Rearden.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Cellply
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cellply
Investment portfolio details for Cellply
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cellply
Detailed financials for Cellply
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cellply Comparisons
Peer comparison for Cellply
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cellply
Cellply operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Kiyatec, Lucid Scientific, DiscoverX, CytoTronics and Saguaro, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Kiyatec is focused on revolutionizing cancer care through predictive platforms.
|
|
| Locked | Locked | Locked |
Real-time cell analyzers are developed for oxygen consumption monitoring.
|
|
| Locked | Locked | Locked |
Develops cell-based assays and provides services for drug discovery and development.
|
|
| Locked | Locked | Locked |
Cell-based assays for drug discovery are developed via CMOS platform.
|
|
| Locked | Locked | Locked |
3D cell culture products are developed for drug discovery applications.
|
Detailed competitors of Cellply
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cellply
Complete news archive for Cellply
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cellply
Cellply was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Cellply is headquartered in Bologna, Italy. It is registered at Bologna, Emilia-romagna, Italy.
Emiliano Spagnolo is the current CEO of Cellply.
Cellply is a funded company, having raised a total of $8.05M across 10 funding rounds to date.
Cellply was founded in 2013 in Bologna, Italy, within the biotechnology sector focused on in-vitro diagnostics. Products for cancer detection are developed, including the ONCOSMART system, which assesses anticancer drug responses in live cells from individual patients. Prognostic tests evaluating immune profiles in hospitalized COVID-19 patients are also provided. Operations center on personalized oncology testing and infectious disease monitoring.
Cellply's top competitors include CytoTronics, Kiyatec and Remedy Plan.
Cellply offers VivaCyte platform.
Cellply has 12 investors. Key investors include European Commission, European Union, Liftt, Meta Group, and Recomec.com.